⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 16, 2024European RadiologyOpen Access

Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children

Vanessa F. Schmidt Özlem Cangir Lutz Meyer Constantin Goldann S Hengst Richard Brill Susanne Heydt Milton Waner Daniel Puhr‐Westerheide Osman Öcal Muzaffer Reha Ümütlü Nabeel Mansour Jan Rudolph Alena Sint Florian Obereisenbuchner Beate Häberle Jens Ricke Max Seidensticker Walter A. Wohlgemuth Moritz Wildgruber

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the safety and clinical outcome of bleomycin electrosclerotherapy (BEST) for treating extracranial slow-flow malformations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schmidt et al. (2024) studied this question.

synapsesocial.com/papers/68e6ee09b6db643587668675 https://doi.org/10.1007/s00330-024-10723-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effectiveness and Safety of Bleomycin Electrosclerotherapy for Slow-Flow Vascular Malformations: A Systematic ReviewSystematic Review · 2026
2Bleomycin Electrosclerotherapy (BEST) for treatment of slow-flow vascular malformations in children2025 · 5 citations
3Therapy of lymphatic malformations or isolated lymphatic components in combined slow-flow malformations with bleomycin electrosclerotherapy (BEST).2025 · 3 citations
4Bleomycin Electrosclerotherapy for Peripheral Low-Flow Venous and Lymphatic Malformations in Children: A Monocentric Case Series2025 · 5 citations
5Bleomycin Electrosclerotherapy in the Treatment of Peripheral Low-Flow Venous and Lymphatic Malformations in Children: Monocentric Preliminary Experience2025